Get started
Author

Rochelle Demsky

The impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation
2011 · A. Finch, K.A. Metcalfe, et al. · Gynecologic Oncology · 202
Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
2012 · Joanne Kotsopoulos, Jan Lubinski, et al. · Breast Cancer Research · 135
PDF
Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study
2016 · Joanne Kotsopoulos, Tomasz Huzarski, et al. · Breast Cancer Research and Treatment · 99
The impact of prophylactic salpingo‐oophorectomy on quality of life and psychological distress in women with a BRCA mutation
2011 · Amy Finch, Kelly A. Metcalfe, et al. · Psycho-Oncology · 93
Routine TP53 testing for breast cancer under age 30: ready for prime time?
2012 · Jeanna M. McCuaig, Susan R. Armel, et al. · Familial Cancer · 84
Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation
2007 · KA Metcalfe, A Poll, et al. · Clinical Genetics · 73
Factors influencing ovulation and the risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
2014 · Joanne Kotsopoulos, Jan Lubinski, et al. · International Journal of Cancer · 70
PDF
Treatment of infertility does not increase the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation
2015 · Jacek Gronwald, Karen Glass, et al. · Fertility and Sterility · 61
PDF
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
2024 · Joanne Kotsopoulos, Jacek Gronwald, et al. · JAMA Oncology · 56
PDF
Effect of decision aid for breast cancer prevention on decisional conflict in women with a BRCA1 or BRCA2 mutation: a multisite, randomized, controlled trial
2016 · Kelly A. Metcalfe, Cindy-Lee Dennis, et al. · Genetics in Medicine · 55
PDF
Oophorectomy after Menopause and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
2012 · Joanne Kotsopoulos, Jan Lubinski, et al. · Cancer Epidemiology Biomarkers & Prevention · 46
Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
2014 · Jacek Gronwald, Andre Robidoux, et al. · Breast Cancer Research and Treatment · 43
Keeping it simple: Genetics referrals for all invasive serous ovarian cancers
2013 · R. Demsky, J. McCuaig, et al. · Gynecologic Oncology · 43
Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: a prospective study,
2016 · Shana J Kim, Anna Zuchniak, et al. · American Journal of Clinical Nutrition · 37
PDF
Folic acid supplement use and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a case–control study
2019 · Shana J. Kim, Cindy X. W. Zhang, et al. · Breast Cancer Research and Treatment · 32
Prospective evaluation of body size and breast cancer risk among BRCA1 and BRCA2 mutation carriers
2018 · Shana J Kim, Tomasz Huzarski, et al. · International Journal of Epidemiology · 28
The sooner the better: Genetic testing following ovarian cancer diagnosis
2015 · E. Fox, J. McCuaig, et al. · Gynecologic Oncology · 26
The Effectiveness of Family History Questionnaires in Cancer Genetic Counseling
2009 · Susan Randall Armel, Jeanna McCuaig, et al. · Journal of Genetic Counseling · 25
PDF
Frequency of Contralateral Prophylactic Mastectomy in Breast Cancer Patients with a Negative BRCA1 and BRCA2 Rapid Genetic Test Result
2021 · Kelly A. Metcalfe, Andrea Eisen, et al. · Annals of Surgical Oncology · 21
Breast and ovarian cancer risk perception after prophylactic salpingo‐oophorectomy due to an inherited mutation in the BRCA1 or BRCA2 gene
2009 · A Finch, K Metcalfe, et al. · Clinical Genetics · 20
Prospective study of high-risk, BRCA1/2-mutation negative women: the ‘negative study’
2014 · Joanne Kotsopoulos, Kelly Metcalfe, et al. · BMC Cancer · 16
PDF
Factors associated with use of hormone therapy after preventive oophorectomy in BRCA mutation carriers
2020 · Javier Mejia-Gomez, Jacek Gronwald, et al. · Menopause The Journal of The North American Menopause Society · 14
Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers
2021 · Neda Stjepanovic, Jan Lubinski, et al. · Breast Cancer Research and Treatment · 12
Predictors of mammographic density among women with a strong family history of breast cancer
2019 · Olivia Moran, Andrea Eisen, et al. · BMC Cancer · 12
PDF
Setting a baseline: A 7-year review of referral rates and outcomes for serous ovarian cancer prior to implementation of oncologist mediated genetic testing
2020 · Susan Randall Armel, Alexandra Volenik, et al. · Gynecologic Oncology · 10
Works count: 42
Citation count: 1,350
H-index: 20
I10-index: 25
Year
Topic
Type